This content, Frequent Questions about the Management Standards for Hazardous Waste Pharmaceuticals Proposed Rule, first appeared on www.epa.gov.
Frequent Questions about the Management Standards for Hazardous Waste Pharmaceuticals Proposed Rule
Question: What is the definition of pharmaceutical under the proposed rule?
Answer: The proposed definition of pharmaceutical is “any chemical or biological product that is intended for use in the diagnosis, cure, mitigation, care, treatment, or prevention of disease or injury of a human or other animal; or any chemical or biological product that is intended to affect the structure or function of the body of a human or other animal. This definition includes, but is not limited to: dietary supplements as defined by the Federal Food, Drug and Cosmetic Act, prescription drugs, over-the-counter drugs, residues of pharmaceuticals remaining in containers, personal protective equipment contaminated with pharmaceuticals, and clean-up material from spills of pharmaceuticals.”
EPA believes a broad definition of pharmaceutical will benefit the healthcare sector, which has struggled with complying with the industry-oriented framework of the RCRA regulations.
This content, Frequent Questions about the Management Standards for Hazardous Waste Pharmaceuticals Proposed Rule, first appeared on www.epa.gov.
